Skip to Content

Drug Interactions between Bridion and drospirenone / ethinyl estradiol / levomefolate calcium

This report displays the potential drug interactions for the following 2 drugs:

  • Bridion (sugammadex)
  • drospirenone/ethinyl estradiol/levomefolate calcium

Edit list (add/remove drugs)

Interactions between your drugs

Major

drospirenone sugammadex

Applies to: drospirenone / ethinyl estradiol / levomefolate calcium and Bridion (sugammadex)

Sugammadex may reduce the blood levels and effects of drospirenone. If you are using hormonal contraceptives, you may have an increased risk of breakthrough bleeding and unintended pregnancy for the next 7 days after receiving sugammadex. You should discuss the use of alternative or additional methods of birth control with your healthcare provider. If you take hormone replacement for menopause, notify your doctor if you experience increased symptoms or abnormal bleeding. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Minor

ethinyl estradiol food

Applies to: drospirenone / ethinyl estradiol / levomefolate calcium

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

For clinical details see professional interaction data.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide